poisar

Stocks · News reference

UBS Maintains Neutral on Dow, Lowers Price Target to $30

BenzingaBenzinga Newsdesk

UBS analyst Joshua Spector maintains Dow (NYSE:DOW) with a Neutral and lowers the price target from $32 to $30.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncResearchandmarkets.Com

    Germany Chemical Licensing Market Outlook Report 2026-2031 | Demand for Compliant, Sustainable Processes Creates Licensing Opportunities in Petrochemicals and Pharma, Global IP Monetization, and Research Partnerships

    Germany's chemical licensing market is projected to grow from USD 1.2 billion in 2026 to USD 1.3 billion by 2031, with a CAGR of 1.6%. Growth is driven by demand for compliant, sustainable chemical technologies across petrochemicals and pharmaceuticals, supported by Germany's advanced industrial infrastructure and regulatory requirements. However, high compliance costs and technical complexity pose challenges, particularly for SMEs.